Diversified Trust Co Sells 2,944 Shares of The Clorox Company (NYSE:CLX)

Diversified Trust Co lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 25.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,729 shares of the company’s stock after selling 2,944 shares during the period. Diversified Trust Co’s holdings in Clorox were worth $1,422,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. GoalVest Advisory LLC acquired a new stake in Clorox during the 1st quarter valued at approximately $31,000. First Foundation Advisors bought a new stake in shares of Clorox in the 1st quarter valued at $31,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. Finally, Quarry LP lifted its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.51% of the stock is owned by corporate insiders.

Clorox Stock Performance

Shares of CLX stock opened at $159.81 on Wednesday. The company has a market capitalization of $19.85 billion, a P/E ratio of 82.78, a PEG ratio of 3.31 and a beta of 0.41. The stock has a 50 day moving average price of $155.44 and a two-hundred day moving average price of $144.48. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Analysts expect that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.05%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Analyst Ratings Changes

Several research analysts have recently weighed in on CLX shares. DA Davidson reissued a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Wells Fargo & Company lowered their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. TD Cowen initiated coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Barclays lifted their price objective on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and boosted their target price for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Six investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $146.13.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.